Showing results (1521-1530 of 3,484) with videos related to
Sort By:
Pageof 349
Matrix Biology : Journal of the International Society for Matrix Biology|January 22, 2011
Hyaluronan deposition and correlation with inflammation in a murine ovalbumin model of asthmaGeorgiana Cheng, Shadi Swaidani, Manisha Sharma, et al.British Heart Journal|September 1, 1978
Effect of aortic valvular regurgitation upon the impedance cardiogramR M Schieken, M R Patel, H L Falsetti, et al.Journal of Surgical Education|June 16, 2015
Global health training in ophthalmology residency programsPeter G Coombs, Brad H Feldman, Andreas K Lauer, et al.Antiviral Research|October 22, 2019
Influences of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replicationYue Ma-Lauer, Yu Zheng, Miroslav Malešević, et al.Journal of Biomechanics|March 3, 2007
Time-frequency changes in electromyographic signals after hamstring lengthening surgery in children with cerebral palsyRichard T Lauer, Brian T Smith, Patricia A Shewokis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1990
Is prophylactic cranial irradiation indicated in small-cell lung cancer?J F Fleck, L H Einhorn, R C Lauer, et al.Toxicology and Applied Pharmacology|December 1, 1987
Immunosuppression following exposure to 7,12-dimethylbenz[a]anthracene (DMBA) in Ah-responsive and Ah-nonresponsive miceL M Thurmond, L D Lauer, R V House, et al.Faraday Discussions|April 7, 2022
Multistep nucleation compatible with a single energy barrier: catching the non-classical culpritA R Lauer, M A Durán-Olivencia, A Fernandez-Martinez, et al.Case Reports in Dentistry|April 1, 2022
Customized Allogeneic Bone Augmentation Improves Esthetic Outcome in Anteromaxillary Dental ImplantationManfred Nilius, Minou Hélène Nilius, Charlotte Mueller, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Intensification with intermediate-dose intravenous methotrexate is effective therapy for children with lower-risk B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group studyD H Mahoney, J J Shuster, R Nitschke, et al.Pageof 349